IGF1R and Familial prostate cancer: Therefore, we evaluated the effect of dansylcadaverine along with the selective IGF1R tyrosine kinase inhibitors AEW541 or tyrphostin AG1024 on cell proliferation in the M12 prostate cancer cell line.